Allogene Therapeutics Inc. (NASDAQ:ALLO) insider David D. Chang bought 40,000 shares of Allogene Therapeutics stock in a transaction that occurred on Monday, October 15th. The shares were acquired at an average price of $18.00 per share, for a total transaction of $720,000.00. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website.
NASDAQ:ALLO opened at $23.80 on Friday. Allogene Therapeutics Inc. has a twelve month low of $21.67 and a twelve month high of $27.72.
Featured Story: Tariff
Receive News & Ratings for Allogene Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allogene Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.